BioSpace News Archive

Lykos Therapeutics announced Allison Rosenthal has been appointed Chief Commercial Officer (CCO) and member of the Company’s executive committee effective immediately.

Probo Medical has announced the hiring of two new executives to their executive team, Greg Kopulos and Ashlyn Jennings, to support the continued growth of the company.

Insmed Incorporated today announced the granting of inducement awards to 63 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed’s Compensation Committee.

Avantor, Inc. announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at approximately 10:00 a.m. Pacific Time.

Viridian Therapeutics, Inc. today announced that a majority of the independent directors serving on the Compensation Committee of the company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 551,000 shares of the company’s common stock.

Curiox Biosystems Co. Ltd, a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announce a strategic partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for flow cytometry.

RevOpsis Therapeutics announced the appointment of Dr. Emmett Cunningham to its Strategic Advisory Board and as a private investor.

Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”), a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), announces that

PharmAla Biotech Holdings Inc. is pleased to announce that it has officially launched its Prescribers Portal for medical practitioners with prescribing power to learn more about MDMA, its effects, and the potential ability to access the molecule for their patients.

Texas Children’s Hospital is pleased to announce the new executive leadership structure at the Texas Children’s Heart Center, which has been ranked number one in the nation for pediatric cardiology and heart surgery by U.S. News and World Report for seven consecutive years.